JPRN-jRCT1091220223尚未招募未知
Effect of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin on Forearm Endothelial Function in Diabetics - EDPI
Bonpei Takase0 个研究点目标入组 30 人开始时间: 2015年8月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Diabetic patients diabetic patients with HbA1c>7.0% (NGSP)
排除标准
- •1. Contraindication of Teneligliptin
- •2. complicated with severe cardiac,renal and liver diseases
- •3. The patients whom the investigating physician disagree with enrollment
研究者
相似试验
招募中
不适用
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysisType 2 diabetic patients on hemodialysisJPRN-UMIN000006024Chibune general hospital5
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
招募中
不适用
Effects of dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000012642Hyogo College of Medicine, Division of Diabetes, Endocrinology & Metabolism200